Navios Maritime Partners L.P. Announces Acquisition of One

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
109
Navios Maritime Partners L.P. Announces Acquisition of One Capesize Vessel

MONACO, May 05, 2017 (GLOBE NEWSWIRE) -- Navios Maritime Partners L.P. ("Navios Partners") (NYSE: NMM ), an international owner and operator of drybulk and container vessels, announced today that it has agreed to acquire one 2009 Japanese-built Capesize vessel of 180,274 dwt for a purchase price of $28.3 million. The vessel is expected to be delivered to Navios Partners' owned fleet by August  2017.

The vessel is expected to generate approximately $3.7 million of annual EBITDA based on the current rate environment (Clarkson’s 1-year time charter rate for Capesize vessels as of April 28, 2017), assuming operating expenses approximating current operating costs and 360 revenue days.

Navios Partners is expected to finance the acquisition with cash on its balance sheet and bank debt on terms consistent with its existing credit facilities.

In the first four months of 2017, Navios Partners has agreed to acquire four drybulk vessels (two Panamax and two Capesize vessels) with a combined capacity of about 500,000 dwt for a total price of about $83.0 million.

Fleet Update Following this acquisition, Navios Partners controls 34 vessels.

About Navios Maritime Partners L.P. Navios Partners (NYSE: NMM ) is a publicly traded master limited partnership which owns and operates container and dry bulk vessels. For more information, please visit our website at www.navios-mlp.com .

Forward-Looking Statements This press release contains forward-looking statements (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events including Navios Partners’ 2017 cash flow generation, future contracted revenues, future distributions and its ability to have a dividend going forward, opportunities to reinvest cash accretively in a fleet renewal program or otherwise, potential capital gains, our ability to take advantage of dislocation in the market and Navios Partners’ growth strategy and measures to implement such strategy; including expected vessel acquisitions and entering into further time charters.  Words such as “may”, “expects”, “intends”, “plans”, “believes”, “anticipates”, “hopes”, “estimates”, and variations of such words and similar expressions are intended to identify forward-looking statements.  Such statements include comments regarding expected revenue and time charters. These forward-looking statements are based on the information available to, and the expectations and assumptions deemed reasonable by Navios Partners at the time these statements were made. Although Navios Partners believes that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct.  These statements involve known and unknown risks and are based upon a number of assumptions and estimates which are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of Navios Partners. Actual results may differ materially from those expressed or implied by such forward-looking statements.  Factors that could cause actual results to differ materially include, but are not limited to, uncertainty relating to global trade, including prices of seaborne commodities and continuing issues related to seaborne volume and ton miles, our continued ability to enter into long-term time charters, our ability to maximize the use of our vessels, expected demand in the dry cargo shipping sector in general and the demand for our Panamax, Capesize, Ultra-Handymax and Container vessels in particular, fluctuations in charter rates for dry cargo carriers and container vessels, the aging of our fleet and resultant increases in operations costs, the loss of any customer or charter or vessel, the financial condition of our customers, changes in the availability and costs of funding due to conditions in the bank market, capital markets and other factors, increases in costs and  expenses, including but not limited to: crew wages, insurance, provisions, port expenses, lube oil, bunkers, repairs, maintenance and  general  and  administrative expenses,  the expected cost  of, and  our ability to  comply with, governmental regulations and maritime self-regulatory organization standards, as well as standard regulations imposed by our charterers applicable to our business, general domestic and international political conditions, competitive factors in the market in which Navios Partners operates; risks associated with operations outside the United States; and other factors listed from time to time in Navios Partners’ filings with the Securities and Exchange Commission, including its Form 20-Fs and Form 6-Ks.  Navios Partners expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in Navios Partners’ expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based. Navios Partners makes no prediction or statement about the performance of its common units.

Public & Investor Relations Contact: Navios Maritime Partners L.P. +1.212.906.8645 Investors@navios-mlp.com Nicolas Bornozis Capital Link, Inc. +1.212.661.7566 naviospartners@capitallink.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 298

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 370

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 158

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 326

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 243

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 209

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 367

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 190

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 0

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 231

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading

Top 5 Most Recently Viewed Articles

Black Hills Corp Celebrates 55 Years of Dividend Increases

Updated Category News Views 210

Black Hills Corp's Remarkable Dividend Achievement Black Hills Corp (NYSE: BKH), a utility company with a significant presence in the energy sector, has achieved a remarkable milestone by raising its quarterly dividend for the 55th consecutive year. This latest increase brings the dividend to $0.676 per share, up from the previous $0.65. This change reflects the...

Continue Reading
Koala Eco and Whole Foods Team Up for Sustainable Care

Updated Category News Views 292

Koala Eco Launches at Whole Foods Market Whole Foods Market is proud to welcome Koala Eco, a brand dedicated to creating sustainable home and self-care products powered by the essence of Australian essential oils. This new partnership is designed to amplify eco-conscious living while providing effective solutions for your body, home, and mind. About Koala Eco and Its...

Continue Reading
Chelsea Lighting Earns Top Recognition in New York Business List

Updated Category News Views 71

Chelsea Lighting Named One of the Best Places to Work in 2024 Chelsea Lighting is excited to announce its inclusion in Crain’s New York Business list of the Best Places to Work for 2024, a recognition it has achieved for three years in a row. This honor highlights the company’s outstanding workplace culture. As a well-respected distributor of value-add lighting...

Continue Reading
AstraZeneca Investors Invited to Take Action Against Losses

Updated Category News Views 144

Investors Encouraged to Act Amid Legal Uncertainties AstraZeneca PLC, known in the biopharmaceutical sector, has caught the attention of investors recently due to legal complications that may significantly affect its stock value. Individuals who acquired AstraZeneca equities during a specific timeframe may now have a chance to lead a class action lawsuit. This opportunity...

Continue Reading
WELL Health and HEALWELL AI to Revolutionize Clinical Trials

Updated Category News Views 223

WELL Health and HEALWELL AI to Revolutionize Clinical Trials WELL Health and HEALWELL AI are excited to announce a significant expansion of their strategic alliance. This multi-year agreement is set to transform clinical trials by enabling management and development at WELL Health clinic locations across the country. With HEALWELL's expertise as a Contract Research...

Continue Reading